Cases
Every significant judgment covering the issue, the holding, where it sits in the Act, what it changed.
Browse all cases →Latest update: . Case: AstraZeneca AB v Intas Pharmaceuticals Limited. Doctrine: Atomic Energy Inventions.
Written and reviewed by Prof. Feroz Ali. A record of the law in practice, how the current doctrines stand and how they are shaped by case law.
Suing on genus and species patents alike indicated dapagliflozin was claimed in both; prior claiming and no technical advance made a credible challenge: interim injunction refused.
A patent in commercial use for nearly five years made out a prima facie case despite a pending revocation petition, and Bajaj obtained an interim injunction against TVS's FLAME.
A refusal resting only on Department of Atomic Energy directions, with no reasons, breached natural justice: order set aside and the application remitted for fresh decision.
Section 4 imposes an embargo in grant of patent in respect of an invention relating to atomic energy, but the amendments to section 4 and 65 of the Patents Act 1970 by the SHANTI Act are yet to fully come into force.
Under section 12, the examiner may raise objections in the first examination report, and the examiner has to act in a quasi-judicial manner and should give a reasoned order.
Under section 2(1)(ac), the fact that something could be considered to be 'a manner of manufacture' does not necessarily mean that it satisfies the conditions specified in s 2 (1)(j).
Two kinds of pages
Every significant judgment covering the issue, the holding, where it sits in the Act, what it changed.
Browse all cases →The law’s evolution under one idea, with the provisions, cases and context in one place. Evolving with the law.
Browse all doctrines →LexCampus books carry short URLs beside every proposition that is likely to change. The book states the law on the day it was published. The URL opens the law as it stands today. The distance between the two is just one click.
Click or Scan this link: www.aop.onl/right-to-exclude
These pages summarise the findings of the courts in their own words. Each page is reviewed, referenced to the relevant doctrine and then published.
These pages take one idea in the law of patents and set out the provisions, the cases and the context in one place. When the law changes, the pages get updated.
Subscribe to our newsletter Changelaw and stay up-to-date on the changes in the record.
By subscribing you agree to our Privacy Policy. Unsubscribe from any email.
Built from this source. Patent Agent Examination 2027 — and the titles that follow.
Trained from this source. The Source Method: small live cohorts with Prof. Ali, taught from the books.